Basic mechanisms of the action of trental (pentoxifylline) on the microcirculation)
Vinnitskiĭ, L.I.
Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 6: 69-70
1979
ISSN/ISBN: 0031-2991 PMID: 232259 Document Number: 146954
Document emailed within 1 workday
Related Documents
Tonak, J.; Knecht, H.; Groitl, H. 1977: Treatment of circulation disorders with pentoxifylline. a double-blind study with Trental Medizinische Monatsschrift 31(10): 467-472Atroshchenko, E.S. 1986: Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries Kardiologiia 26(12): 106-108
Srivastava, M.; Ambrus, J.L. 1993: Differentiation of acute promyelocytic leukemia cell induced by 1,25-dihydroxyvitamin D3 and pentoxifylline (Trental) Research Communications in Chemical Pathology and Pharmacology 79(3): 385-388
Pemler, K.; Penth, B.; Adams, H.J. 1979: Pentoxifylline medication within the scope of leg-ulcer therapy. Results of a field study using Trental 400 Fortschritte der Medizin 97(21): 1019-1022
Reilly, D.T.; Quinton, D.N.; Barrie, W.W. 1987: A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects New Zealand Medical Journal 100(828): 445-447
Nakanishi, S.; Fukagawa, M. 2008: Basic and clinical aspects of calcimimetics. Cinacalcet, effect and mechanisms of action Clinical Calcium 18(1): 20-26
Müller, R.; Lebrach, F. 1980: Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline Pharmatherapeutica 2(6): 372-379
Gilbert, E.; Hui, A.; Waldorf, H.A. 2012: The basic science of dermal fillers: past and present Part I: background and mechanisms of action Journal of Drugs in Dermatology: Jdd 11(9): 1059-1068
Remennik, O.I.; Dudka, P.F.; Il'nitskiĭ, R.I. 1988: The mechanism of the action of trental Vrachebnoe Delo 4: 50-54
Youle, R J. 2003: Haya Lorberboum-Galski and Philip Lazarovici (Eds.). Chimeric Toxins: Mechanisms of Action and Therapeutic Applications (Cell and Molecular Mechanisms of Toxin Action) International Journal of Toxicology 22(4): 331-332
Johnson, F.E.; Tolman, K.C.; Farr, S.A.; Davis, P.J.; Ludden, T.M.; Roy, T.K.; Raju, P.I. 1993: Serum levels of pentoxifylline and its metabolites in non-tumor-bearing mice after chronic oral pentoxifylline administration Journal of Medicine 24(2-3): 131-143
Rozova, K.V.; Sydoriak, N.H. 2014: Mechanisms of changes of microcirculation in rats under acute methemoglobinemia Fiziolohichnyi Zhurnal 60(5): 43-51
Zaccaria, A.; Antonini, M.; Marciani, A.; Taurino, M.; Speziale, F.; Spartera, C. 1981: Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities La Ricerca in Clinica e in Laboratorio 11(Suppl 1): 381-386
Sukovatykh, B.S.; Kniazev, V.V. 2007: The mechanisms of critical impairments of microcirculation in patients with chronic ischemia of lower extremities Vestnik Khirurgii Imeni I. I. Grekova 166(4): 20-24
Költringer, P.; Langsteger, W.; Lind, P.; Klima, G.; Wakonig, P.; Eber, O. 1988: The microcirculation as a parameter of peripheral thyroid hormone action Acta Medica Austriaca 15(Suppl 1): 64-65
Bauer, M.; Zhang, J.X.; Bauer, I.; Clemens, M.G. 1994: ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action American Journal of Physiology 267(1 Pt 1): G143-G149
Kovalenko, N.I.; Chernukh, A.M. 1979: Comparative study of the action of histamine, serotonin and bradykinin on the liver microcirculation in rats Vestnik Akademii Meditsinskikh Nauk SSSR 4: 34-40
Henderson, A.H. 1983: Basic mechanisms of calcium antagonists Postgraduate Medical Journal 59(Suppl 2): 7-10
Lassmann, H. 1997: Basic mechanisms of brain inflammation Journal of Neural Transmission. Supplementum 50: 183-190
Hansen, J.M.øl.; Ashina, M. 2016: Basic mechanisms of migraine and new methods of treatment Ugeskrift for Laeger 178(51)